{'fraction_non_alphanumeric': 0.016842105263157894, 'fraction_numerical': 0.009473684210526316, 'mean_word_length': 5.604166666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
MP47-19 UNDERREPRESENTATION OF HISPANICS AND AMERICAN INDIAN/ALASKA NATIVES IN THE NATIONAL CANCER DATABASE

than 60 years and without comorbidities. Figure 1 depicts the risk of other cause mortality versus risk of recurrence following surgery for non-metastatic renal cell carcinoma according to age and cT stage in patients with no comorbidities or in presence of comorbidities. The continuous lines depict the risk of recurrence that decreases with time. Vertical lines depict the mean time to recurrence and associated 95% confidence interval calculated with mean restricted survival time. Dashed lines depict other cause mortality risk, which increases with time. CONCLUSIONS: Our findings can help selecting the optimal candidates for multidisciplinary evaluations and to consider RCC patients for clinical trials, deferred treatment, and treatment policy improvement, especially in the case of major healthcare disruptions, such as pandemics.